Trilegal, AZB act on Canadian $1.5m Delhi medical research company buy

Wednesday, 6 May 2015 By Prachi Shrivastava Corporate M&A

Trilegal and Canadian law firm Osler, Hoskin & Harcourt advised the largest Canadian contract research organisation (CRO) JSS Medical Research on its Rs 9.5 crore ($1.5m) buy of CRO Max Neeman Medical International which was advised by AZB & Partners.

Trilegal partner Charandeep Kaur, counsel Ramakant Rai and associate Jatin Vyas, and Osler Montreal-based managing partner Shahir Guindi and associate Geneviève Burdon acted for JSS

AZB Delhi partners Anil Kasturi and Niladri Maulik and associate Siddharth Khanna acted for Max.

MNMI, part of the Max India group which split three-way , provides clinical development services to small, mid-size and global pharmaceutical, biotech and medical device companies, according to VCCircle.

TrilegalAZB & Partners

Comments

money for nothing 6 May 2015, 13:02
+8 -1
I bought a 1.5 million dollar house from a builder in south delhi.. I acted for myself..news worthy? slow Wednesday afternoon Kian?
kianganz 6 May 2015, 13:04
+2 -0
No, sorry, unless you paid yourself legal fees?
which locality 6 May 2015, 13:11
+2 -0
Congrats - where did you buy it? BHK? How many reserved parking:-)
Guest 6 May 2015, 13:09
+0 -0
what is the basis for LI to chose or decline to publish deal updates? Just curious. Does it depends on the stature of the firms involved?
kianganz 6 May 2015, 13:14
+0 -0
No, it's a bit random but here are a number of parameters that make it into the mix:

- how many firms involved? Do we know all partners?
- how big is the deal?
- how interesting is the sector / deal / cross-border?
- is it an exclusive deal?
- how recent is it?
- do we have any other deals currently sitting there awaiting publication?
- has it been reported in the business papers?
- is it a deal by a start-up or other firm we haven't reported on very often before?
Aston 6 May 2015, 16:51
+0 -0
some clients may not want deal to be covered by LI !
Top-tier 6 May 2015, 13:15
+3 -1
So supposedly AZB and Trilegal ditched the billion dollar Lanco deal and gave it to HSA so that they could do this one?
2cents 6 May 2015, 13:52
+5 -1
Correct. Deal value is not always directly proportionate to legal fees earned. Actually, deal value is not always a direct reflection of deal complexity either. But you already know this but still want to stir up the pot anyway... because you can!
mainasehta 6 May 2015, 16:56
+0 -0
Clinical research would have meant full regulatory framework DD waah trilegal waah
Blah! 25 Jun 2015, 13:59
+0 -0
But the deal value certainly impacts the legal fee. Nobody would want to spend high just to buy peanuts.
Je baat 6 May 2015, 13:25
+2 -0
That is right. He who pays, wins.
Mrky 6 May 2015, 19:52
+0 -0
1.5 million is approx 10 crores... Young lawyers will realize this only when the legal bubble bursts.. Let foreign law firms enter india who would only hire 5+ years experienced and freshers fir research and others would cry...
Commenting is closed for this article.